The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Co-codamol 15 mg/500 mg film-coated tablets



Azure Pharmaceuticals LtdPA22871/020/001

Main Information

Trade NameCo-codamol 15 mg/500 mg film-coated tablets
Active SubstancesParacetamol
Codeine phosphate hemihydrate
Dosage FormFilm-coated tablet
Licence HolderAzure Pharmaceuticals Ltd
Licence NumberPA22871/020/001

Group Information

ATC CodeN02AJ06 codeine and paracetamol

Status

License statusAuthorised
Licence Issued12/08/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back